Showing results (21-30 of 538) with videos related to
Sort By:
Pageof 54
Journal of Cancer Policy|January 29, 2026
Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014Celeste Cagnazzo, Evaristo Maiello, Roberto Labianca, et al.Endocrine-Related Cancer|December 3, 2005
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancerNicola Normanno, Massimo Di Maio, Ermelinda De Maio, et al.BMC Cancer|July 26, 2006
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinomaCiro Gallo, Ermelinda De Maio, Massimo Di Maio, et al.World Journal of Gastroenterology|March 20, 2008
Is human hepatocellular carcinoma a hormone-responsive tumor?Massimo Di Maio, Bruno Daniele, Sandro Pignata, et al.Expert Opinion on Drug Safety|March 31, 2010
Vinorelbine for non-small cell lung cancerMaria Carmela Piccirillo, Gennaro Daniele, Massimo Di Maio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancerMassimo Di Maio, Francesco Perrone, Paolo Chiodini, et al.Expert Review of Anticancer Therapy|March 25, 2016
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cyclesAntonio Rossi, Massimo Di MaioJournal of Thoracic Disease|June 29, 2018
A review of guidelines for lung cancerPaolo Bironzo, Massimo Di MaioExpert Opinion on Pharmacotherapy|January 8, 2010
The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trialCesare Gridelli, Massimo Di MaioMed (New York, N.Y.)|April 12, 2025
eNRGy: Making progress toward a future for NRG1 fusion-positive cancerLucia Anna Muscarella, Massimo Di MaioPageof 54